Wedbush Starts Imperva (IMPV) at Neutral; Compelling Play, But Fully Valued...Wait For Pullback
Tweet
Share
E-mailGet Alerts IMPV Hot Sheet
Price: $55.74 --0%
Rating Summary:
10 Buy, 19 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
10 Buy, 19 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Wedbush initiates coverage on Imperva (NYSE: IMPV) with a Neutral. PT $34.00.
Analyst, Rohit Chopra, said, "We believe the LT outlook for the company is positive given its positioning as a leading player in one of the fastest growing segments of the security market, data security, which is growing at 20%+ y/y...Our enthusiasm for the secular tailwinds is tempered by a premium valuation which leaves little room for error, near-term spending, lack of near-term profitability and global macro issues, especially in Europe. We would be more constructive given a pullback in the shares, improvements in the IT spending environment and visibility into the ramp of profitability."
For an analyst ratings summary and ratings history on Imperva click here. For more ratings news on Imperva click here.
Shares of Imperva closed at $29.46 yesterday.
Analyst, Rohit Chopra, said, "We believe the LT outlook for the company is positive given its positioning as a leading player in one of the fastest growing segments of the security market, data security, which is growing at 20%+ y/y...Our enthusiasm for the secular tailwinds is tempered by a premium valuation which leaves little room for error, near-term spending, lack of near-term profitability and global macro issues, especially in Europe. We would be more constructive given a pullback in the shares, improvements in the IT spending environment and visibility into the ramp of profitability."
For an analyst ratings summary and ratings history on Imperva click here. For more ratings news on Imperva click here.
Shares of Imperva closed at $29.46 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ICICI Securities Resumes Oberoi Realty Ltd (OBER:IN) at Buy (1)
- RBC Capital Starts Krystal Biotech (KRYS) at Outperform
- Evercore ISI Starts Alvotech SA (ALVO) at Outperform
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
